Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001437749-25-004256
Filing Date
2025-02-18
Accepted
2025-02-18 17:25:41
Documents
4
Period of Report
2025-04-16

Document Format Files

Seq Description Document Type Size
1 FORM PRE 14A nby20250209_pre14a.htm PRE 14A 570453
2 a01.jpg GRAPHIC 118814
3 a02.jpg GRAPHIC 123743
4 logo.jpg GRAPHIC 3886
  Complete submission text file 0001437749-25-004256.txt   910927
Mailing Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608
Business Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608 (510) 899-8800
NovaBay Pharmaceuticals, Inc. (Filer) CIK: 0001389545 (see all company filings)

EIN.: 680454536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-33678 | Film No.: 25636212
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)